Profile data is unavailable for this security.
About the company
OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. The Company’s segments include pharmaceutical and diagnostics. The pharmaceutical segment consists of the pharmaceutical operations it operates in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its global pharmaceutical research and development operations. The diagnostics segment primarily consists of clinical laboratory operations through BioReference and its point-of-care operations. Its pharmaceutical business features Somatrogon (hGH-CTP), a once-weekly human growth hormone injection, and it is marketed under the brand name NGENLA. The Company, through its pharmaceutical division, manufactures and sells Rayaldee, a United States Food and Drug Administration (FDA) approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.
- Revenue in USD (TTM)642.07m
- Net income in USD-180.40m
- Incorporated1991
- Employees3.00k
- LocationOPKO Health Inc4400 Biscayne Blvd.MIAMI 33137United StatesUSA
- Phone+1 (305) 575-4181
- Websitehttps://www.opko.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Enhabit Inc | 1.05bn | -11.90m | 564.78m | 10.70k | -- | 0.9963 | 36.91 | 0.539 | -0.2476 | -0.2476 | 20.60 | 11.20 | 0.8275 | -- | 6.99 | 97,925.23 | -0.7976 | -- | -0.9216 | -- | 48.98 | 50.47 | -0.9639 | -1.55 | -- | 1.35 | 0.4371 | -- | -1.10 | -1.07 | -94.04 | -- | -20.68 | -- |
| AMN Healthcare Services Inc | 2.72bn | -275.54m | 624.22m | 2.97k | -- | 0.9666 | -- | 0.2298 | -7.20 | -7.20 | 70.73 | 16.81 | 1.13 | -- | 5.65 | 915,401.90 | -11.46 | 6.72 | -14.71 | 8.97 | 29.37 | 32.55 | -10.14 | 4.92 | -- | 0.796 | 0.5679 | 0.00 | -21.26 | 6.07 | -169.76 | -- | 17.28 | -- |
| Talkspace Inc | 214.59m | 4.24m | 624.52m | 521.00 | 159.61 | 5.71 | 95.80 | 2.91 | 0.0236 | 0.0236 | 1.20 | 0.6608 | 1.61 | -- | 17.50 | 411,886.80 | 3.17 | -28.33 | 3.71 | -34.24 | 43.27 | 52.11 | 1.98 | -28.25 | -- | -- | 0.00 | -- | 25.02 | 37.49 | 105.98 | -- | 108.54 | -- |
| Sonida Senior Living Inc | 375.42m | -52.14m | 640.61m | 3.42k | -- | 21.55 | 594.25 | 1.71 | -2.88 | -2.88 | 20.76 | 4.31 | 0.4548 | -- | 14.61 | 109,931.80 | -5.88 | -6.59 | -6.63 | -8.36 | -- | -- | -12.94 | -17.54 | -- | -0.3943 | 0.8879 | -- | 19.19 | -7.41 | 70.94 | -- | 4.39 | -- |
| Omada Health Inc | 232.34m | -26.19m | 654.94m | 859.00 | -- | 3.01 | -- | 2.82 | -0.4679 | -0.4679 | 4.13 | 3.75 | -- | -- | -- | 273,665.50 | -- | -- | -- | -- | 64.31 | -- | -11.27 | -- | 3.59 | -745.00 | 0.00 | -- | 38.29 | -- | 30.18 | -- | -- | -- |
| Nutex Health Inc | 981.20m | 120.57m | 705.14m | 880.00 | 5.85 | 2.17 | 2.48 | 0.7187 | 17.04 | 17.04 | 147.16 | 45.93 | 1.40 | 162.97 | 4.26 | 1,226,495.00 | 37.53 | -32.14 | 52.14 | -41.13 | 55.01 | 25.98 | 26.83 | -41.43 | 3.18 | 16.10 | 0.4267 | -- | 93.80 | 222.94 | 213.78 | -- | 93.93 | -- |
| Fulgent Genetics Inc | 315.55m | -42.98m | 724.28m | 1.31k | -- | 0.6421 | -- | 2.30 | -1.40 | -1.40 | 10.28 | 36.49 | 0.2578 | -- | 4.91 | 240,326.70 | -3.61 | 12.18 | -3.82 | 13.30 | 41.24 | 64.76 | -14.00 | 24.57 | -- | -- | 0.0026 | 0.00 | -1.99 | 54.19 | 74.55 | -- | 102.57 | -- |
| Teladoc Health Inc | 2.53bn | -223.59m | 824.68m | 5.50k | -- | 0.5924 | 6.10 | 0.3262 | -1.28 | -1.28 | 14.45 | 7.85 | 0.7892 | 19.86 | 11.96 | 459,672.50 | -6.98 | -33.76 | -8.82 | -35.27 | 69.80 | 69.21 | -8.84 | -147.54 | 2.60 | -- | 0.4166 | -- | -1.26 | 35.95 | -354.35 | -- | 62.64 | -- |
| Astrana Health Inc | 2.90bn | 9.54m | 941.92m | 1.90k | 99.01 | 1.20 | 19.95 | 0.3252 | 0.1897 | 0.1897 | 59.23 | 15.70 | 1.64 | -- | 9.82 | 1,524,450.00 | 0.5528 | 6.98 | 0.6496 | 8.46 | 10.25 | 16.79 | 0.3362 | 5.34 | -- | 2.78 | 0.6543 | 9.34 | 46.72 | 29.41 | -28.93 | 25.04 | 50.46 | -- |
| OPKO Health Inc | 642.07m | -180.40m | 944.27m | 3.00k | -- | 0.7243 | -- | 1.47 | -0.2406 | -0.2406 | 0.8806 | 1.70 | 0.302 | 6.68 | 6.38 | 214,236.20 | -8.48 | -5.03 | -9.32 | -5.70 | 35.29 | 33.63 | -28.09 | -9.82 | 3.32 | -2.22 | 0.211 | -- | -17.41 | -4.59 | 71.82 | -- | 14.44 | -- |
| Clover Health Investments Corp | 1.77bn | -57.71m | 1.04bn | 570.00 | -- | 3.00 | -- | 0.5885 | -0.1143 | -0.1156 | 3.52 | 0.6726 | 2.93 | -- | 32.18 | 3,111,516.00 | -9.52 | -31.80 | -15.61 | -48.76 | -- | -- | -3.25 | -21.26 | -- | -- | 0.00 | -- | 8.77 | -- | 77.98 | -- | -- | -- |
| Pennant Group Inc | 847.27m | 26.70m | 1.11bn | 7.00k | 42.27 | 3.43 | 29.16 | 1.31 | 0.7563 | 0.7563 | 24.00 | 9.31 | 1.21 | -- | 9.41 | 121,039.10 | 4.27 | 2.38 | 5.15 | 2.81 | 20.13 | 21.05 | 3.53 | 2.48 | -- | 11.26 | 0.0705 | 0.00 | 27.59 | 15.48 | 68.61 | 54.70 | 24.78 | -- |
| InnovAge Holding Corp | 915.37m | 6.47m | 1.13bn | 2.44k | 179.63 | 4.42 | 51.35 | 1.24 | 0.0465 | 0.0465 | 6.74 | 1.89 | 1.74 | -- | 25.76 | 375,152.50 | 0.6333 | -5.80 | 0.9505 | -7.87 | 20.34 | 19.12 | 0.364 | -4.25 | -- | 6.50 | 0.1927 | -- | 11.76 | 8.52 | -42.06 | -- | -11.96 | -- |
| US Physical Therapy Inc | 758.71m | 36.02m | 1.32bn | 4.03k | 36.58 | 2.62 | 15.59 | 1.74 | 2.38 | 2.38 | 50.06 | 33.12 | 0.6819 | -- | 9.01 | 188,079.10 | 5.51 | 5.82 | 8.03 | 8.54 | 18.80 | 21.02 | 8.08 | 8.61 | -- | 12.98 | 0.17 | 68.72 | 11.00 | 6.85 | 52.86 | -2.37 | -2.05 | 9.07 |
| Lumexa Imaging Holdings Inc | 1.00bn | -43.47m | 1.36bn | 4.06k | -- | 8.13 | -- | 1.35 | -0.4597 | -0.4597 | 10.61 | 1.77 | -- | -- | -- | 246,893.50 | -- | -- | -- | -- | 13.66 | -- | -4.33 | -- | -- | 0.5332 | 0.8806 | -- | 1.38 | -- | 23.01 | -- | -- | -- |
Data as of Feb 13 2026. Currency figures normalised to OPKO Health Inc's reporting currency: US Dollar USD
19.92%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Rubric Capital Management LPas of 31 Dec 2025 | 47.79m | 6.23% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 31.23m | 4.07% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 29.25m | 3.81% |
| Geode Capital Management LLCas of 31 Dec 2025 | 11.06m | 1.44% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 8.95m | 1.17% |
| KSM Mutual Funds Ltd.as of 30 Nov 2025 | 5.63m | 0.73% |
| Goldman Sachs Asset Management LPas of 31 Dec 2025 | 4.99m | 0.65% |
| Whitefort Capital Management, LPas of 30 Sep 2025 | 4.90m | 0.64% |
| UBS Securities LLCas of 31 Dec 2025 | 4.64m | 0.60% |
| Migdal Mutual Funds Ltd.as of 30 Nov 2025 | 4.48m | 0.58% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
